Increased expression of transglutaminase 2 drives glycolytic metabolism in renal carcinoma cells

Depletion of cathepsin D by transglutaminase 2 through protein cross-linking promotes cell survival

(2011) Se-Jin Kim et al.   AMINO ACIDS

Understanding the central role of citrate in the metabolism of cancer cells

(2011) Philippe Icard et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Cancer cells promote survival through depletion of the von Hippel–Lindau tumor suppressor by protein crosslinking

(2011) D-S Kim et al.   ONCOGENE

Inhibition of aconitase in citrus fruit callus results in a metabolic shift towards amino acid biosynthesis

(2011) Asfaw Degu et al.   PLANTA

Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors

(2011) Lee E. Moore et al.   PLoS Genetics

Transglutaminase 2: A multi-tasking protein in the complex circuitry of inflammation and cancer

(2010) Kapil Mehta et al.   BIOCHEMICAL PHARMACOLOGY

Metabolic profiling reveals key metabolic features of renal cell carcinoma

(2009) Gareth Catchpole et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-κB activity in hypoxic tumor cells

(2009) G -Y Jang et al.   ONCOGENE